Thursday, October 31, 2019 6:37:21 PM
Surely I believe that those who received DCVax-L initially, rather than after progressing on the SOC should do better when essentially the two are identical on discovery. The thing is, people are not identical. Some people might be cured even if the tumor were found late, whereas others won't be, even if it was discovered early.
I do think the Dr. doing the treatment can make a big difference, even though all the Doctors have access to all the same tools. I met people my age and older at City of Hope that excellent hospitals elsewhere would not treat with stem cells. Why? Because they knew the risk was greater, and they don't want to harm themselves statistically. Meanwhile COH gets excellent results with seniors because they do it frequently, and they know how to make it work. Dr. Liau certainly seems like someone you'd want on your team if confronted with GBM, and I'd trust her judgement in what course of action to take. I also suspect that under right to try, she'd have access to DCVax-L even if no trials were currently taking in patients.
In the future I suspect that many cancers will be identified very early because of blood tests that are in development. If a cancer can be detected in the blood before a mass can be found, perhaps DCVax-Direct can be created and given and the cancer treated far earlier than any symptoms would be seen to cause a search for it. I was found to have a mass in the kidneys after the removal of a skin cancer, sebaceous carcinoma, which was considered dangerous enough to do a scan of my body after it's removal by Mohs surgery. The mass was determine to be cancerous, but that was after four levels of experts checked it, alternating between benign and cancerous as it went higher through the chain. My point is that it might not have proved to be a problem for years, but when it was, it almost definitely would have cost me the kidney. As it was, because of where it was it was touch and go as to whether they could save the kidney, but in the end they were able to. I certainly can't say I was lucky, but I have had 3 potentially deadly cancer in my life that have been successfully treated to date that don't count less threatening skin cancers that were more easily dealt with.
I also suspect are bodies might routinely eliminate minor cancers before they become a problem. Early detection may find some of these, so we may end up treating cancers that would never be a problem without treatment. The problem is, it's impossible to know what will and what won't become a problem. I know in some cases where the seniors are found with prostate cancer it's monitored and only treated if it's deemed to be a threat as it may be so slow growing that old age will likely take the patient before the prostate cancer becomes a problem.
Gary
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM